JENNISON ASSOCIATES LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 247 filers reported holding SAGE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
JENNISON ASSOCIATES LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$33,070,000
-30.8%
582,120
-8.8%
0.02%
-37.1%
Q1 2021$47,779,000
-2.1%
638,326
+13.2%
0.04%0.0%
Q4 2020$48,789,000
+82.1%
563,968
+28.7%
0.04%
+59.1%
Q3 2020$26,793,000
+195.3%
438,365
+100.9%
0.02%
+175.0%
Q2 2020$9,074,000
+45.2%
218,238
+0.3%
0.01%0.0%
Q1 2020$6,251,000
-83.1%
217,667
-57.4%
0.01%
-78.4%
Q4 2019$36,919,000
-91.0%
511,409
-82.5%
0.04%
-91.5%
Q3 2019$410,164,000
-24.2%
2,923,689
-1.0%
0.43%
-19.4%
Q2 2019$540,832,000
+44.4%
2,953,913
+25.4%
0.54%
+44.4%
Q1 2019$374,660,000
+336.7%
2,355,614
+163.0%
0.37%
+287.5%
Q4 2018$85,796,000
-25.0%
895,664
+10.5%
0.10%
-8.6%
Q3 2018$114,444,000
-9.2%
810,224
+0.6%
0.10%
-14.6%
Q2 2018$126,063,000
-1.1%
805,361
+1.8%
0.12%
-3.1%
Q1 2018$127,410,000
+14.0%
791,023
+16.5%
0.13%
+15.5%
Q4 2017$111,790,000
+69.8%
678,707
-35.8%
0.11%
+61.8%
Q3 2017$65,836,000
-38.2%
1,056,750
-20.9%
0.07%
-39.8%
Q2 2017$106,457,000
+12.5%
1,336,728
+0.4%
0.11%
+10.8%
Q1 2017$94,660,000
+95.5%
1,331,922
+40.4%
0.10%
+88.9%
Q4 2016$48,429,000
+27.4%
948,475
+14.9%
0.05%
+31.7%
Q3 2016$38,026,000
+191.2%
825,744
+90.5%
0.04%
+192.9%
Q2 2016$13,059,000
-5.6%
433,411
+0.4%
0.01%
-6.7%
Q1 2016$13,835,000
-7.0%
431,545
+69.1%
0.02%0.0%
Q4 2015$14,875,000255,1450.02%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders